跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
林 時宜
教授
,
一般醫學學科
合聘教授
,
臨床醫學研究所
合聘教授
,
生物科技高階管理碩士專班
主治醫師
,
臺北醫學大學附設醫院
https://orcid.org/0000-0001-6751-5533
電子郵件
sylin
tmu.edu
tw
,
221014
h.tmu.edu
tw
h-index
3588
引文
36
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1991 …
2024
每年研究成果
概覽
指紋
網路
專案
(28)
研究成果
(139)
資料集
(5)
類似的個人檔案
(6)
指紋
查看啟用 Shyr-Yi Lin 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
95%
Malignant Neoplasm
91%
Colon Cancer
61%
Liver Cell Carcinoma
57%
Mouse
54%
Protein P53
52%
Phosphotransferase
47%
Antioxidant
43%
Nanocarrier
40%
Osthole
40%
Colorectal Cancer
38%
Cytotoxicity
35%
Chitosan
33%
Vitis
33%
Bispecific Antibody
32%
Combination Therapy
30%
Docetaxel
30%
Epidermal Growth Factor Receptor
30%
Hydroxamic Acid
30%
Prostaglandin J2
30%
Egg Lecithin
30%
IC50
29%
Macrogol
27%
Antioxidant Capacity
25%
Carcinogenesis
25%
Nude Mouse
24%
Hot Water
23%
Caspase 8
22%
Pancreas Cancer
22%
Stomach Cancer
22%
Nicotine-Derived Nitrosamine Ketone
22%
Breast Cancer
22%
Hydrogen Peroxide
21%
Liver Cancer
21%
Liposome
21%
Methanol
21%
Cytotoxicity
21%
Poloxamer
20%
Chronic Hepatitis C
20%
Nicotinic Receptor
20%
Epidermal Growth Factor Receptor 2
20%
Gamma Urogastrone
20%
Carcinogen
20%
Nanoemulsion
20%
Terfenadine
20%
Terbinafine
20%
Magnolol
20%
Bioavailability
20%
Antibodies
20%
Antihypertensive Activity
20%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
Colon
51%
Cell Proliferation
34%
Promoter Region
34%
Methylation
26%
P53
25%
Alternative Splicing
25%
Caspase 8
23%
Phosphotransferase
23%
Kinase
23%
Codon
22%
P21
22%
Restriction Site
21%
Synapsin I
21%
Carcinogenesis
20%
Caveolin 1
20%
TSG101
20%
G1/S Transition
20%
Protein P53
20%
Monocyte
20%
Heme Oxygenase
20%
Haemophilia A
20%
Upregulation
18%
Mouse
18%
Point Mutation
16%
Signal Transduction
16%
Genetics
16%
Exon
16%
Glucose Transport
15%
Messenger RNA
14%
Tumor Suppressor Gene
14%
Western Blot
13%
Extracellular Signal-Regulated Kinases
13%
down Regulation
13%
Gene Expression
13%
Prostaglandin
13%
Cell Cycle Arrest
13%
Polymerase Chain Reaction
12%
Glucose Transporter
12%
Cytochrome
12%
Salvia Miltiorrhiza
12%
DNA Mutation
12%
Nude Mouse
11%
Hepatitis C Virus
11%
Ribonuclease
11%
Virus Replication
11%
Wound Healing
11%
Messenger RNA
11%
RNA Binding
10%
Cell Cycle Checkpoint
10%
Medicine and Dentistry
Protein P53
40%
Malignant Neoplasm
37%
In Vitro
34%
Medicine
26%
Hepatocellular Carcinoma
26%
Neoplasm
23%
Gastrointestinal Cancer
21%
Acute Pancreatitis
20%
Osthole
20%
Cohort Effect
20%
Restriction Site
20%
Chronic Hepatitis C
20%
Cohort Analysis
20%
Glycosylation
20%
Codon
19%
Carcinogenesis
15%
Prevalence
15%
Glucose Uptake
15%
Colorectal Cancer
14%
Stomach Cancer
14%
Cell Proliferation
14%
Colon Cancer
14%
Cancer Cell
13%
Point Mutation
13%
Mitogen-Activated Protein Kinase
13%
Cancer Cell Line
13%
Mortality Rate
13%
IC50
12%
T Cell
12%
p38 Mitogen-Activated Protein Kinase
11%
Skeletal Muscle Cell
11%
Odds Ratio
11%
Antioxidant
11%
Lipid Diet
11%
Gene Mutation
11%
Liver Cirrhosis
11%
Hepatoma Cell
11%
Hyperglycemia
10%
Diabetes
10%
Programmed Cell Death
10%
Tumor Cell
10%
Cell Surface
10%
Mitogen Activated Protein Kinase P38
10%
Acquired Immune Deficiency Syndrome
10%
Endothelial Cell
10%
Knee
10%
Reactive Oxygen Species
10%
Glycation
10%
Fatty Acid
10%
Meal
10%
